Consumer Driven Health Care

Pharmaceutical companies don't have nearly the access to doctors that they once enjoyed.

A potential change in federal patent law for generic drugs could raise federal health care costs by $1.3 billion over the next decade, according to an estimate by the Congressional Budget Office.

After peaking around the holidays last year, sales of wearable health trackers has slowed significantly, according to a new report from Argus Insights.

The cost of prescription drugs has risen steadily over the past decade and shows no sign of stopping.

There may not be many individuals with health savings accounts who use the investment option such accounts offer, but those who do contribute more, and their balances are larger.

Sprouts controversial "female Viagra" pill received approval on Tuesday from the FDA--now Valeant is buying Sprout.